Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling

[1]  A. Ullrich,et al.  FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. , 2006, Cellular signalling.

[2]  S. Milstien,et al.  Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. , 2006, Cancer cell.

[3]  Yiling Lu,et al.  Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. , 2006, Cancer cell.

[4]  Andries Zijlstra,et al.  Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. , 2005, Cancer research.

[5]  G. Davis,et al.  Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization , 2005 .

[6]  Chiung-Nien Chen,et al.  Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. , 2005, Endocrinology.

[7]  K. Kikuchi,et al.  Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate* , 2005, Journal of Biological Chemistry.

[8]  G. Davis,et al.  MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices , 2005, Journal of Cell Science.

[9]  R. Ala-aho,et al.  Matrix metalloproteinases as therapeutic targets in cancer. , 2005, Current cancer drug targets.

[10]  T. Ludwig,et al.  Microtubule-Dependent Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Exocytosis , 2004, Cancer Research.

[11]  Steven Shapiro,et al.  Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP , 2004, The Journal of cell biology.

[12]  E. Goetzl,et al.  Sphingosine 1‐phosphate and its G protein‐coupled receptors constitute a multifunctional immunoregulatory system , 2004, Journal of cellular biochemistry.

[13]  J. Brown,et al.  G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival , 2004, Journal of cellular biochemistry.

[14]  B. Giepmans,et al.  The ins and outs of lysophosphatidic acid signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  J. Saba.  Lysophospholipids in development: Miles apart and edging in , 2004, Journal of cellular biochemistry.

[16]  Evi Kostenis,et al.  Novel clusters of receptors for sphingosine‐1‐phosphate, sphingosylphosphorylcholine, and (lyso)‐phosphatidic acid: New receptors for “Old” ligands , 2004, Journal of cellular biochemistry.

[17]  D. Gingras,et al.  Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. , 2004, Blood.

[18]  T. Hla,et al.  Point-Counterpoint of Sphingosine 1-Phosphate Metabolism , 2004, Circulation research.

[19]  B. Haye,et al.  TIMPs as multifacial proteins. , 2004, Critical reviews in oncology/hematology.

[20]  Y. Morishita,et al.  Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1* , 2004, Journal of Biological Chemistry.

[21]  G. Davis,et al.  Integrin expression in human melanoma cells with differing invasive and metastatic properties , 1992, Clinical & Experimental Metastasis.

[22]  M. Seiki,et al.  MT-MMPs play pivotal roles in cancer dissemination , 2004, Clinical & Experimental Metastasis.

[23]  Kayla J Bayless,et al.  Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. , 2003, Biochemical and biophysical research communications.

[24]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[25]  H. Mori,et al.  Membrane-type 1 matrix metalloproteinase and cell migration. , 2003, Biochemical Society symposium.

[26]  G. Mills,et al.  Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. , 2003, Cancer research.

[27]  G. Mills,et al.  The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.

[28]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[29]  Motoharu Seiki,et al.  Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. , 2003, Cancer letters.

[30]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[31]  T. Hla.  Signaling and biological actions of sphingosine 1-phosphate. , 2003, Pharmacological research.

[32]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[33]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[34]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[35]  J. Chun,et al.  Lysophosphatidic acid as a novel cell survival/apoptotic factor. , 2002, Biochimica et biophysica acta.

[36]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[37]  Kenneth M. Yamada,et al.  Cell interactions with three-dimensional matrices. , 2002, Current opinion in cell biology.

[38]  Y. Itoh,et al.  Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.

[39]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[40]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[41]  T. Panetti.  Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. , 2002, Biochimica et biophysica acta.

[42]  D. Manning,et al.  Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. , 2002, Biochimica et biophysica acta.

[43]  T. Hla,et al.  Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. , 2002, Biochimica et biophysica acta.

[44]  Kazuki Nabeshima,et al.  Matrix metalloproteinases in tumor invasion: Role for cell migration , 2002, Pathology international.

[45]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[46]  G. Davis,et al.  The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. , 2002, Journal of cell science.

[47]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[48]  G. Mills,et al.  Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. , 2002, Cancer treatment and research.

[49]  A. Strongin,et al.  Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) , 2001, The Journal of Biological Chemistry.

[50]  S. Zucker,et al.  Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. , 2001, Drug discovery today.

[51]  D. Fishman,et al.  Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. , 2001, Cancer research.

[52]  John G. Collard,et al.  Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. , 2001, Seminars in cancer biology.

[53]  W. Stetler-Stevenson,et al.  Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.

[54]  C. Der,et al.  Rho GTPase-dependent transformation by G protein-coupled receptors , 2001, Oncogene.

[55]  N. Sugimoto,et al.  Inhibitory Regulation of Rac Activation, Membrane Ruffling, and Cell Migration by the G Protein-Coupled Sphingosine-1-Phosphate Receptor EDG5 but Not EDG1 or EDG3 , 2000 .

[56]  L. Van Aelst,et al.  Rho GTPases: signaling, migration, and invasion. , 2000, Experimental cell research.

[57]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[58]  Stephen J. Weiss,et al.  Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.

[59]  E. Goetzl,et al.  Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. , 2000, American journal of physiology. Cell physiology.

[60]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[61]  W. Moolenaar.  Bioactive lysophospholipids and their G protein-coupled receptors. , 1999, Experimental cell research.

[62]  G. Davis,et al.  Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein, and profilin during capillary morphogenesis in vitro. , 1999, Experimental cell research.

[63]  M Markman,et al.  Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.

[64]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Y. Okada,et al.  Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.

[66]  G. Davis,et al.  An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. , 1996, Experimental cell research.

[67]  R. Rubin.  The war on cancer. , 1996, U.S. news & world report.

[68]  W. Moolenaar,et al.  Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger (*) , 1995, The Journal of Biological Chemistry.

[69]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[70]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[71]  C. Marshall,et al.  Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells , 1987, Cell.

[72]  Suraiya Rasheed,et al.  Characterization of a newly derived human sarcoma cell line (HT‐1080) , 1974, Cancer.

[73]  Bornstein Mb,et al.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. , 1958, Laboratory investigation; a journal of technical methods and pathology.